BioInvent International AB
STO:BINV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
BioInvent International AB
STO:BINV
|
SE |
|
Lords & Company Worldwide Holdings Inc
F:4XM
|
CA |
|
M
|
Mitie Group PLC
OTC:MITFY
|
UK |
|
P
|
Pungguk Ethanol Co Ltd
KOSDAQ:023900
|
KR |
|
P
|
PagerDuty Inc
F:2TY
|
US |
|
Energeia AS
F:F620
|
NO |
|
I
|
Inchcape PLC
F:IJCA
|
UK |
|
A
|
Atrys Health SA
MAD:ATRY
|
ES |
|
Enghouse Systems Ltd
F:3E4
|
CA |
|
A
|
Acushnet Holdings Corp
F:163
|
US |
|
T
|
T S Flour Mill PCL
SET:TMILL
|
TH |
|
Savills PLC
LSE:SVS
|
UK |
|
N
|
Novo Nordisk A/S
OTC:NONOF
|
DK |
|
R
|
Ramada Investimentos e Industria SA
F:Y4E
|
PT |
|
W
|
Wiable Corp
KOSDAQ:065530
|
KR |
Intrinsic Value
Is BINV undervalued or overvalued?
See the intrinsic value estimate for BioInvent International AB and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
BINV looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with BINV’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What BioInvent International AB Does
BioInvent International AB is a Swedish biotech company that discovers and develops antibody-based medicines, mainly for cancer. It does not sell consumer products; instead, it creates drug candidates and research tools that are meant to be tested in clinical studies and then licensed or partnered with larger drugmakers. Its work centers on finding antibodies that can help the immune system attack tumors or block signals that cancer cells use to grow.
- Headquarters
- Sweden SE
- Employees
- 112
- IPO date
- Jun 12, 2001
Revenue & Expenses Breakdown
BioInvent International AB
Earnings Waterfall
BioInvent International AB
The intrinsic value for BioInvent International AB (BINV) under the Base Case is hidden SEK.
Compared with the current market price of 20.5 SEK, the stock appears hidden.